Figure 3
From: Characterisation of the vitreous proteome in proliferative diabetic retinopathy
Validation of the downregulation of clusterin and PEDF in the PDR vitreous by Western blot analysis. (A) Western blot analyses of vitreous samples showing lower levels of PEDF (50 kDa) and clusterin (33 kDa) in the vitreous fluid of ten PDR patients. C (control group), P (PDR group), and M (marker). (B) and (C) Densitometric analyses of the vitreous PEDF and clusterin levels. Vitreous PEDF and clusterin levels in the PDR group were lower than those of the control group. (p < 0.01).